Screening of antiviral activity of samples from chaga Inonotus obliquus and humic acid from brown coal on Vero cell culture against ectromelia virus (Poxviridae: Orthopoxvirus; ECTV)
- Authors: Teplyakova T.V.1, Kabanov A.S.1, Ovchinnikova A.S.1, Odnoshevskyh D.A.1, Petrovskaya I.F.1, Nepomnyashchikh T.S.1, Pyankov O.V.1
-
Affiliations:
- State Research Center of Virology and Biotechnology “Vector” of Rospotrebnadzor
- Issue: Vol 68, No 4 (2023)
- Pages: 277-282
- Section: ORIGINAL RESEARCH
- URL: https://journals.rcsi.science/0507-4088/article/view/133986
- DOI: https://doi.org/10.36233/0507-4088-174
- EDN: https://elibrary.ru/scsivx
- ID: 133986
Cite item
Full Text
Abstract
Introduction. The mouse-specific orthopoxvirus, ectromelia virus, is one of the best models that can be used to study key issues of pathogenesis, prevention, and treatment of smallpox, and to develop measures to increase virulence, transmissibility, or the ability to overcome vaccine immunity.
The aim of the work is to screen the antiviral activity of samples from Inonotus obliquus chaga and humic acid from brown coal in vitro against ectromelia virus.
Materials and methods. We used ectromelia virus, strain K-1 (reg. No V-142), obtained from the State Collection of Pathogens of Viral Infections and Rickettsioses of the State Scientific Center of Virology and Biotechnology “Vector”; Vero Е6 cell culture (No 70) from the Collection of cell cultures of the State Scientific Center of Virology and Biotechnology “Vector”. Nine samples from chaga I. obliquus and humic acid from brown coal were used to evaluate the changes in the infectivity of the ectromelia virus on cell culture using 2 schemes of application of drugs and virus (preventive and therapeutic schemes), and to assess their cytotoxicity and antiviral activity.
Results. 50% cytotoxic concentration, 50% virus-inhibiting concentrations and selectivity index were determined for all samples. The studied samples were shown to be non-toxic to the monolayer of Vero cell culture in a dilution of 300 and more micrograms/ml, while demonstrated high antiviral activity against strain K-1 of ectromelia virus in two application schemes – preventive and curative.
Conclusion. All samples tested for ectromelia virus in vitro can be considered promising for further development of drugs against diseases caused by orthopoxviruses.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Tamara V. Teplyakova
State Research Center of Virology and Biotechnology “Vector” of Rospotrebnadzor
Author for correspondence.
Email: teplyakova@vector.nsc.ru
ORCID iD: 0000-0002-0621-8698
D. Sci. (Biol.), Professor, leading researcher, Department of Biophysics and Ecological Research
Russian Federation, 630559, Koltsovo, Novosibirsk RegionAlexey S. Kabanov
State Research Center of Virology and Biotechnology “Vector” of Rospotrebnadzor
Email: teplyakova@vector.nsc.ru
ORCID iD: 0000-0002-6287-0912
Cand. Sci. (Biol.), senior researcher, Department "Collection of microorganisms"
Russian Federation, 630559, Koltsovo, Novosibirsk RegionAlena S. Ovchinnikova
State Research Center of Virology and Biotechnology “Vector” of Rospotrebnadzor
Email: teplyakova@vector.nsc.ru
ORCID iD: 0000-0002-1745-7643
Cand. Sci. (Biol.), senior researcher, Department "Collection of microorganisms"
Russian Federation, 630559, Koltsovo, Novosibirsk RegionDmitry A. Odnoshevskyh
State Research Center of Virology and Biotechnology “Vector” of Rospotrebnadzor
Email: teplyakova@vector.nsc.ru
ORCID iD: 0000-0003-0616-7488
junior researcher, Department "Collection of microorganisms"
Russian Federation, 630559, Koltsovo, Novosibirsk RegionIrina F. Petrovskaya
State Research Center of Virology and Biotechnology “Vector” of Rospotrebnadzor
Email: teplyakova@vector.nsc.ru
ORCID iD: 0000-0002-9833-0555
trainee researcher, Department of Biophysics and Ecological Research
Russian Federation, 630559, Koltsovo, Novosibirsk RegionTatiana S. Nepomnyashchikh
State Research Center of Virology and Biotechnology “Vector” of Rospotrebnadzor
Email: teplyakova@vector.nsc.ru
ORCID iD: 0000-0003-0592-8273
Cand. Sci. (Biol.), Academic Secretary
Russian Federation, 630559, Koltsovo, Novosibirsk RegionOleg V. Pyankov
State Research Center of Virology and Biotechnology “Vector” of Rospotrebnadzor
Email: teplyakova@vector.nsc.ru
Cand. Sci. (Biol.), senior researcher, head of the Department "Collection of microorganisms"
Russian Federation, 630559, Koltsovo, Novosibirsk RegionReferences
- Fenner F., Buller R.M. Mousepox. In: Nathanson R.A.N., Gonzalez-Scarano F., Griffin D.E., Holmes K.V., Murphy F.A., Robinson H.L., eds. Viral Pathogenesis. Philadelphia, PA: Lippincott-Raven; 1997: 535–53.
- Jordan R., Hruby D. Smallpox antiviral drug development: satisfying the animal efficacy rule. Expert Rev. Anti Infect. Ther. 2006; 4(2): 277–89. https://doi.org/10.1586/14787210.4.2.277
- Buller R.M. Mousepox: a small animal model for biodefense research. Appl. Biosaf. 2004; 9(1): 10–9.
- Kabanov A.S., Sergeev Al.A., Bulychev L.E., Bormotov N.I., Shishkina L.N., Sergeev Ar.A., et al. Studies of anti-viral activity of chemically synthesized compounds against orthopoxviruses in vitro. Problemy osobo opasnykh infektsiy. 2013; (2): 54–9. https://elibrary.ru/qbzekx (in Russian)
- Teplyakova T.V., P’yankov O.V., Skarnovich M.O., Bormotov N.I., Kosogova T.A., Ovchinnikova A.S., et al. Inhibitor of SARS-CoV-2 coronavirus replication based on an aqueous extract of Inonotus obligus fungus. Patent RF № 2741714; 2021. (in Russian)
- Teplyakova T.V., P’yankov O.V., Skarnovich M.O., Bormotov N.I., Poteshkina A.L., Ovchinnikova A.S., et al. A melanin-based inhibitor of SARS-CoV-2 coronavirus replication from the fungus Inonotus obliquus. Patent RF № 2747018; 2021. (in Russian)
- Teplyakova T.V., P’yankov O.V., Skarnovich M.O., Bormotov N.I., Poteshkina A.L., Ovchinnikova A.S., et al. Inhibitor of SARS-CoV coronavirus replication-2 based on humic substances. Patent RF № 2752872; 2021. (in Russian)
- Baker R.O., Bray M., Huggins J.W. Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections. Antiviral Res. 2003; 57(1-2): 13–23. https://doi.org/10.1016/s0166-3542(02)00196-1
- Khabriev R.U., ed. Guidelines for the Experimental (Preclinical) Study of New Pharmacological Substances [Rukovodstvo po eksperimental’nomu (doklinicheskomu) izucheniyu novykh farmakologicheskikh veshchestv]. Moscow: Meditsina; 2005. (in Russian)
- Sachs L. Statistische auswertungsmethoden. Berlin, Heidelberg, New York: Springer-Verlag; 1972.
- Teplyakova T.V., Bulychev L.E., Kosogova T.A., Ibragimova Zh.B., Yurganova I.A., Kabanov A.S., et al. Antiviral activity of extracts from basidiomycetes for orthopoxviruses. Problemy osobo opasnykh infektsiy. 2012; (3): 99–101. https://elibrary.ru/pekrcb (in Russian)
- Teplyakova T.V., Pyankov O.V., Safatov A.S., Ovchinnikova A.S., Kosogova T.A., Skarnovich M.O., et al. Water extract of the Chaga medicinal mushroom, Inonotus obliquus (Agaricomycetes), inhibits SARS-CoV-2 replication in vero E6 and vero cell culture experiments. Int. J. Med. Mushrooms. 2022; 24(2): 23–30. https://doi.org/10.1615/intjmedmushrooms.2021042012
Supplementary files
